Market Overview

Spectrum Pharmaceuticals Appoints Former Amgen Executive as Senior Vice President of Sales


Spectrum Pharmaceuticals (NASDAQ: SPPI) today announced the
appointment of Joseph Turgeon as Senior Vice President Sales &
Commercial Operations. Mr. Turgeon will be responsible for the
commercialization and sales of all Spectrum products; currently,
Spectrum markets FUSILEV® (levoleucovorin) for Injection;
FOLOTYN® (pralatrexate injection); and ZEVALIN®
(ibritumomab tiuxetan) Injection for intravenous use. Mr. Turgeon brings
over 25 years of pharma sales experience, including various executive
leadership roles at Amgen. He will report to Ken Keller, Executive Vice
President and Chief Operating Officer.

“With three anticancer drugs on the market now bringing

See full press release

Posted-In: Earnings News Guidance Management Global


Related Articles (SPPI)

View Comments and Join the Discussion!